Riber Reports 5% Revenue Growth in 2024

Riber, a leader in molecular beam epitaxy (MBE) equipment, announced a 5% increase in revenues for 2024, totaling €41.2 million. This aligns with its business targets. The growth reflects robust performance despite a challenging fourth quarter comparison. MBE systems revenue rose 7% to €31 million, with 12 systems delivered, slightly below the previous year's 13.

The services and accessories segment remained stable with €10.2 million. Geographically, Asia accounted for 57.3% of the revenue, followed by Europe at 35.7%, and North America at 7.1%. The order book stood at €21.7 million by the year-end, influenced by two new January 2025 orders.

Looking ahead, Riber aims for continued earnings growth, spurred by innovations in semiconductor materials and entrance into silicon photonics. It expects revenue growth in 2025 based on the current order book composition and upcoming deliveries.